NCT00407173View on ClinicalTrials.gov

Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Healthy
Interventions
DRUG

HCV-796

HCV-796 1000mg single dose

Trial Locations (2)

19148

Philadelphia

32608

Gainesville

Sponsors

Collaborators (1)

ViroPharma
All Listed Sponsors
collaborator

ViroPharma

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00407173 - Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects | Biotech Hunter | Biotech Hunter